Perspective Therapeutics CATX
NYSE CATX
$2.98 -0.14 (-4.49%)
As of: Sep 9, 2026 · 3:59 PM EDT

Perspective Therapeutics (CATX) Debt Ratio (2023 - 2026)

Perspective Therapeutics' (CATX) quarterly Debt Ratio came in at 0.0 in Q2 2026, down 23.33% year-over-year from 0.01 in Q2 2025, and up 3.94% quarter-over-quarter from 0.0 in Q1 2026.

Analysis

Perspective Therapeutics (CATX) Debt Ratio (2023 - 2026) Analysis & Trends

Perspective Therapeutics has disclosed Debt Ratio across 4 years of filings, most recently posting 0.0 for Q2 2026.

  • In Q2 2026, Debt Ratio fell 23.33% year-over-year to 0.0; the TTM figure through Jun 2026 stood at 0.0 (down 23.33% YoY), while the FY2025 annual figure was 0.01, up 23.8% from the prior year.
  • Debt Ratio came in at 0.0 for Q2 2026 at Perspective Therapeutics, up from 0.0 in the prior quarter.
  • In the past five years, Debt Ratio ranged from a high of 0.02 in Q4 2023 to a low of 0.0 in Q1 2026.
  • Average Debt Ratio over 4 years is 0.01, with a median of 0.01 recorded in 2025.
  • Year-over-year, Debt Ratio tumbled 73.27% in 2024 and rose 28.67% in 2025.
  • Over 4 years, Debt Ratio stood at 0.02 in 2023, then slumped by 72.1% to 0.0 in 2024, then increased by 23.8% to 0.01 in 2025, then tumbled by 33.07% to 0.0 in 2026.
  • Per Business Quant data, the three most recent Debt Ratio figures were 0.0 in Q2 2026, 0.0 in Q1 2026, and 0.01 in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn 0.66
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn 0.58
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn -
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn 0.05
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn -
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn 0.05
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn -
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn 0.25
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn 0.26
10 Perspective Therapeutics 358.23 Mn 358.23 Mn - 0.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 0.00
Mar 31, 2026 0.00
Dec 31, 2025 0.01
Sep 30, 2025 0.01
Jun 30, 2025 0.01
Mar 31, 2025 0.01
Dec 31, 2024 0.00
Sep 30, 2024 0.00
Jun 30, 2024 0.00
Mar 31, 2024 0.01
Dec 31, 2023 0.02
Sep 30, 2023 0.02
Jun 30, 2023 0.02
Mar 31, 2023 0.01